To investigate the clinical features, diagnosis and treatment of infectious mononucleosis (IM) in children.
From January 2018 to February 2020, 36 children with IM in the department of pediatrics of Shanghai oriental hospital were selected as the research objects, and their clinical manifestations, laboratory tests and treatment were retrospectively analyzed.
There were 36 cases of IM children, the main clinical manifestations were lymphadenitis (97.22%), fever (86.11%), pharyngeal tonsillitis (77.78%), hepatomegaly (33.33%), splenomegaly (47.22%), eyelid edema (33.33%) and rash (8.33%). There were significant differences in the incidence of splenomegaly among children of different ages (P<0.05), and children of school age and adolescence were more likely to have splenomegaly than children. Leukocytes increased (61.11%), and heterotypic lymphocytes≥10% (94.44%). Epstein-Barr virus (EBV) antibodies, induding EBV-viral capsid antigen (VCA)-immunoglobulin (Ig)M antibody, EBV-VCA-IgG antibody, EBV-VCA-IgA antibody, EBV-early antigen (EA)-IgA antibody, EBV-EA-IgG antibody and EBV-nuclear antigen-IgG antibody, were detected in 33 children. The positive rates of them were 87.88%, 57.58%, 33.33%, 27.27%, 18.18% and 0, respectively. 14 cases were mycoplasma positive, 1 case was influenza virus positive and 1 case was rhinovirus positive. The complications were granulocytopenia (61.11%), liver function damage (52.78%), anemia (47.22%), myocardial damage (44.44%) and respiratory tract infection (41.67%). 88.89% of the children received antiviral therapy with ganciclovir, and all of them received symptomatic and supportive treatment, with good prognosis.
IM is more common in preschool children aged 3-6 years. There are differences in clinical characteristics among children of different ages. EBV antibody detection is helpful for diagnosis, and EBV-DNA detection can be used for diagnosis and evaluation of the disease, which is worthy of promotion. Clinical treatment with ganciclovir antiviral and symptomatic treatment, the curative effect and prognosis are good.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |